{"id":"W2790637078","doi":"10.1186/s12962-018-0089-8","title":"Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US","year":2018,"lang":"en","type":"article","venue":"Cost Effectiveness and Resource Allocation","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"University of British Columbia; Canadian Lung Association; Reseau canadien de recherche respiratoire; Canadian Thoracic Society; Institute of Circulatory and Respiratory Health; Michael Smith Health Research BC; GlaxoSmithKline; British Columbia Lung Association; Canadian Institutes of Health Research; AstraZeneca Canada; AstraZeneca","keywords":"Omalizumab; Medicine; Asthma; Tiotropium bromide; Quality-adjusted life year; Cost effectiveness; Intensive care medicine; Internal medicine; Pediatrics; Immunoglobulin E; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007144395,0.0002120331,0.0005267066,0.0002019385,0.0001266419,0.00001620236,0.00007713121,0.0001585529,0.00001275611],"category_scores_gemma":[0.0003384461,0.0001729333,0.0001279311,0.0002740964,0.0002603719,0.00007495245,0.00003638182,0.00009970213,0.000004898006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001727424,"about_ca_system_score_gemma":0.0001467909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006259618,"about_ca_topic_score_gemma":0.00004675217,"domain_scores_codex":[0.998383,0.0004851033,0.0002760199,0.000398766,0.0001933979,0.0002637261],"domain_scores_gemma":[0.998192,0.0009619293,0.0001306001,0.0002563729,0.0003214848,0.0001376547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.25431,0.002857139,0.1868497,0.007710404,0.0009394568,0.00007017476,0.0009930899,0.003093361,0.1417622,0.002877836,0.0001555532,0.3983811],"study_design_scores_gemma":[0.03185622,0.00350058,0.9254571,0.0009538887,0.0001419232,0.00001131673,0.0002141639,0.002925379,0.0211807,0.00006441709,0.01345149,0.0002428618],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890516,0.0009649475,0.00544584,0.0000517297,0.0002145153,0.003761843,0.00001644489,0.00003471835,0.0004583434],"genre_scores_gemma":[0.9987063,0.00002585913,0.00004908839,0.00004196622,0.0002051214,0.0008472796,0.0000645093,0.00003265889,0.00002724884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7386073,"threshold_uncertainty_score":0.7052014,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02799356763001311,"score_gpt":0.3211294701530908,"score_spread":0.2931359025230777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}